Shionogi Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Shionogi Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3435
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shionogi Inc (Shionogi), a subsidiary of Shionogi & Co., Ltd, is a pharmaceutical company that develops and commercializes pharmaceutical products to address the unmet medical needs. The company offers a wide range of branded prescription products to treat chronic diseases. It markets products for various therapeutic areas such as pain, anti-infectives, women’s health, pediatrics, cardiovascular and others. Shionogi offers its products in various formulations such as tablets, oral suspensions (solutions), lotions, capsules, chewable tablets and injections. Some of the company’s key branded products include Doribax, Fortamet, Methylin, Ponstel and Xodol, among others. Shionogi is headquartered in Florham Park, New Jersey, the US.

Shionogi Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shionogi Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shionogi Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Shionogi Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Noven Pharma Enters Into Co-Promotion Agreement With Shionogi For Brisdelle Capsules 10
Licensing Agreements 11
Pharmbio Korea Enters into Licensing Agreement with Shionogi 11
Duchesnay Receives Rights for Osphena from Shionogi 12
Plethora Solutions Enters Into Commercialization Agreement With Shionogi For PSD502 13
Concordia Pharma And Shionogi Enter Into Licensing Agreement For Ulesfia 14
Equity Offering 15
PharmaIN to Raise USD17 Million in Private Placement of Shares 15
Asset Transactions 16
Pragma Pharma Acquires Keflex from Shionogi 16
Alvogen Acquires Rights Of Naprelan Tablets From Shionogi 17
Concordia Pharma Acquires Rights To Three US Pediatrics From Shionogi 18
Merz Pharma Acquires Cuvposa from Shionogi 19
Shionogi Inc – Key Competitors 20
Shionogi Inc – Key Employees 21
Shionogi Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Corporate Communications 23
May 09, 2018: Shionogi to Announce Executive Appointment 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Shionogi Inc, Pharmaceuticals & Healthcare, Key Facts 2
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shionogi Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shionogi Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Shionogi Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Noven Pharma Enters Into Co-Promotion Agreement With Shionogi For Brisdelle Capsules 10
Pharmbio Korea Enters into Licensing Agreement with Shionogi 11
Duchesnay Receives Rights for Osphena from Shionogi 12
Plethora Solutions Enters Into Commercialization Agreement With Shionogi For PSD502 13
Concordia Pharma And Shionogi Enter Into Licensing Agreement For Ulesfia 14
PharmaIN to Raise USD17 Million in Private Placement of Shares 15
Pragma Pharma Acquires Keflex from Shionogi 16
Alvogen Acquires Rights Of Naprelan Tablets From Shionogi 17
Concordia Pharma Acquires Rights To Three US Pediatrics From Shionogi 18
Merz Pharma Acquires Cuvposa from Shionogi 19
Shionogi Inc, Key Competitors 20
Shionogi Inc, Key Employees 21

List of Figures
Shionogi Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shionogi Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Shionogi Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sonic Healthcare Limited:企業の戦略・SWOT・財務情報
    Sonic Healthcare Limited - Strategy, SWOT and Corporate Finance Report Summary Sonic Healthcare Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ID Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary ID Pharma Co Ltd (ID Pharma), formerly DNAVEC Corp is a manufacturer and commercializer of gene medicines. The company develops regenerative medicines, cell therapy and other bio products. It provides vector platforms such as Sendai virus vector in its drug development process. ID Pharma’s v …
  • LyondellBasell Industries NV (LYB):石油・ガス:M&Aディール及び事業提携情報
    Summary LyondellBasell Industries NV (LyondellBasell) is a chemical company. It produces and sells petrochemicals, plastics and basic chemicals. The company also refines crude oil to convert into refined products such as gasoline, diesel and jet fuel. Its major chemical products include polyolefins …
  • Oxford Gene Technology Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford Gene Technology Ltd (OGT) is a provider of genetics research solutions. The company’s products comprise fish probes, custom cancer panels, custom AML panel, custom breast cancer panel, custom FH panel, core MPN panel, ovarian cancer panel, myeloid panel and others. It provides medical …
  • Kikkoman Corp:企業の戦略・SWOT・財務情報
    Kikkoman Corp - Strategy, SWOT and Corporate Finance Report Summary Kikkoman Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Huhtamaki Oyj:企業のM&A・事業提携・投資動向
    Huhtamaki Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Huhtamaki Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Karyopharm Therapeutics Inc (KPTI):企業の財務・戦略的SWOT分析
    Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Genmab AS (GEN):企業の財務・戦略的SWOT分析
    Genmab AS (GEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Avitide Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avitide Inc (Avitide) strives to discover, manufacture and commercialize molecule-specific affinity purification solutions for biopharmaceutical industry. It offers affinity purification resins for developing bio-molecules including enzymes, non-antibody therapeutics, bispecific antibodies, …
  • BASF Corp:企業の戦略的SWOT分析
    BASF Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Welltower Inc
    Welltower Inc - Strategy, SWOT and Corporate Finance Report Summary Welltower Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Meidensha Corporation:企業の戦略・SWOT・財務分析
    Meidensha Corporation - Strategy, SWOT and Corporate Finance Report Summary Meidensha Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mesa Air Group, Inc.:企業の戦略・SWOT・財務情報
    Mesa Air Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mesa Air Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Aphios Corp-製薬・医療分野:企業M&A・提携分析
    Summary Aphios Corp (Aphios) is a biotechnology company that develops nanotechnology drug delivery platforms. The company provides technology platforms and enhanced therapeutics for the treatment of infectious diseases, cancers and central nervous system disorders. Its therapeutic products include Z …
  • TherOx Inc:医療機器:M&Aディール及び事業提携情報
    Summary TherOx Inc (TherOx) is a medical device company that develops and commercializes SuperSaturated Oxygen (SSO2) therapies for treatment of heart attack. Its SSO2 therapy is designed to ameliorate progressive myocardial necrosis by minimizing microvascular damage in heart attack patients. TherO …
  • Twoxar Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Twoxar Inc (Twoxar) is an artificial intelligence-driven drug discovery company that develops novel drug candidates. The company’s drug discovery technology platform evaluates public and proprietary datasets to identify high probability drug-disease matches based on orders of magnitude. Its …
  • PG&E Corporation:企業の戦略・SWOT・財務情報
    PG&E Corporation - Strategy, SWOT and Corporate Finance Report Summary PG&E Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • FUJIFILM Holdings Corporation:企業の戦略・SWOT・財務分析
    FUJIFILM Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary FUJIFILM Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Senshu Ikeda Holdings Inc:企業の戦略・SWOT・財務情報
    Senshu Ikeda Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Senshu Ikeda Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Epinex Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Epinex Diagnostics Inc (Epinex) is a medical device company that offers rapid diagnostic tests. The company’s products comprise point-of-care test device and over-the-counter test device. Its Epinex G1A system is rapid diabetes monitoring index test for the control of glycation. Epinex offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆